TBnet webinar September 2022




We welcome you to the TBnet monthly webinar dedicated to "TBnet in conversation with TB proof: Doing advocacy" on September 29, 2022, at 04:00 PM (CEST).

In this webinar we will hear from Goodman Makanda from TB Proof as he discusses his experience as a DR-TB survivor and TB activist. TB proof is an advocacy group aiming to eliminate TB by combining stories and science by involving affected communities. It was started in 2012 by health workers who developed occupational TB and students passionate about TB prevention. TB proof's initial focus was on preventing the spread of TB in healthcare facilities through advocacy and education. Since then, they have expanded their advocacy efforts to include access to high quality TB treatment, addressing stigma and improving support to people affected by TB.


Together Goodman and Jess will explore what it means to be an advocate and what advocacy can contribute to the TB research agenda.


Following Goodman's story, we look forward to opening up the webinar for further discussion with people from TB affected communities, researchers and healthcare workers to think about how we can w​ork in partnership to end TB.


Join us on Zoom!

Time: September 29, 2022 at 4:00 PM (CEST)

Link: https://us06web.zoom.us/j/82332433401?pwd=eGNqWWpNdW43dnlsN3RCQ21PU2VKZz09

Meeting ID: 823 3243 3401 Passcode: 813410

 

OUR SPEAKER:


Goodman Makanda, TB Proof, South Africa. Goodman is a DR-TB survivor and passionate TB activist from Khayelitsha, Cape Town. Goodman wants his TB journey to inspire others that are currently on TB treatment to keep fighting and to do advocacy for better TB treatment and diagnostics too.

 

CHAIR OF THE WEBINAR:


Jess Potter, Advocacy Lead, TBnet. Jess is a TB specialist, public health researcher and activist. Her research focuses on access to health care and the structural conditions that shape these experiences. She campaigns to end TB and for the healthcare rights of migrants.


 





39 views0 comments

Recent Posts

See All